Eagle Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| STANLEY-LAMAN GROUP, LTD. | 10/22/2025 | 12.00 K | $32.40 K | 0.00% | 0.09% |
| ARCHER INVESTMENT CORP | 11/03/2025 | 350 | $945 | 0.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Eagle Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 67 institutional investors and hedge funds held shares of Eagle Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Stanley-Laman Group, Ltd.: 12,000
Archer Investment Corp: 350
DGS Capital Management, LLC: 0
AJOVista, LLC: 56,438
BlackRock Inc.: 352,762
Point72 Middle East FZE: 6,543
0.09% of Eagle Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.52 M shares in the last 24 months. This purchase volume represents approximately $7.53 M in transactions.